Award recordCONTRACT

ALBA BIOSCIENCE, INC.

PIID 36C25522N0282· VHA· 255-NETWORK CONTRACT OFFICE 15 (36C255)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2022· $40,062 net obligations· UEI V6KNKL6BDHL7· PA

Description

BLOOD BANK LIQUID REAGENTS FOR MULTIPLE LOCATIONS.

First action · last action
2022-06-21 · 2025-01-27
Transactions
9
First transaction's obligation
$49,728
Base + all options value (sum of deltas)
$40,062
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25520A0034
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 9 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$49,728$0Base award · 2022-06-21 · this action $49,728 · running total $49,728Modification P00001 · 2023-12-19 · this action -$2,336 · running total $47,392Modification P00002 · 2024-05-15 · this action -$120 · running total $47,272Modification P00003 · 2024-06-04 · this action -$773 · running total $46,499Modification P00004 · 2024-06-07 · this action -$1,552 · running total $44,947Modification P00005 · 2024-09-11 · this action -$738 · running total $44,208Modification P00006 · 2024-09-13 · this action -$909 · running total $43,300Modification P00007 · 2024-11-04 · this action -$1,686 · running total $41,614Modification P00008 · 2025-01-27 · this action -$1,552 · running total $40,062
  • Base2022-06-21+$49,728= $49,728
  • Mod P000012023-12-19-$2,336= $47,392
  • Mod P000022024-05-15-$120= $47,272
  • Mod P000032024-06-04-$773= $46,499
  • Mod P000042024-06-07-$1,552= $44,947
  • Mod P000052024-09-11-$738= $44,208
  • Mod P000062024-09-13-$909= $43,300
  • Mod P000072024-11-04-$1,686= $41,614
  • Mod P000082025-01-27-$1,552= $40,062
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2022-06-21+$49,728$49,728BLOOD BANK LIQUID REAGENTS FOR MULTIPLE LOCATIONS.
Mod P00001· FUNDING ONLY ACTION2023-12-19−$2,336$47,392BLOOD BANK LIQUID REAGENTS FOR MULTIPLE LOCATIONS.
Mod P00002· FUNDING ONLY ACTION2024-05-15−$120$47,272BLOOD BANK LIQUID REAGENTS FOR MULTIPLE LOCATIONS.
Mod P00003· FUNDING ONLY ACTION2024-06-04−$773$46,499BLOOD BANK LIQUID REAGENTS FOR MULTIPLE LOCATIONS.
Mod P00004· FUNDING ONLY ACTION2024-06-07−$1,552$44,947BLOOD BANK LIQUID REAGENTS FOR MULTIPLE LOCATIONS.
Mod P00005· FUNDING ONLY ACTION2024-09-11−$738$44,208BLOOD BANK LIQUID REAGENTS FOR MULTIPLE LOCATIONS.
Mod P00006· FUNDING ONLY ACTION2024-09-13−$909$43,300BLOOD BANK LIQUID REAGENTS FOR MULTIPLE LOCATIONS.
Mod P00007· FUNDING ONLY ACTION2024-11-04−$1,686$41,614BLOOD BANK LIQUID REAGENTS FOR MULTIPLE LOCATIONS.
Mod P00008· FUNDING ONLY ACTION2025-01-27−$1,552$40,062BLOOD BANK LIQUID REAGENTS FOR MULTIPLE LOCATIONS.

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI V6KNKL6BDHL7)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0306255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$40,949FY2026
36C25926N0280NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$64,078FY2026
36C25726N0176257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$7,634FY2026
36C25726N0224257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$16,514FY2026
36C25626N0214256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$23,127FY2026
36C25026N0043250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$21,884FY2026

Other recipients under 6550 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25526N0405FISHER SCIENTIFIC COMPANY L.L.C.255-NETWORK CONTRACT OFFICE 15 (36C255)$113,611FY2026
36C25526N0337CEPHEID255-NETWORK CONTRACT OFFICE 15 (36C255)$2,571,141FY2026
36C25526N0307WERFEN USA LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$76,810FY2026
36C25526N0312QUIDELORTHO SALES COMPANY, LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$21,363FY2026
36C25526A0030QUIDELORTHO SALES COMPANY, LLC255-NETWORK CONTRACT OFFICE 15 (36C255)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25522N0282_3600_36C25520A0034_3600 · retrieved 2026-09-26.